Administration, Intravaginal
"Administration, Intravaginal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
Descriptor ID |
D000282
|
MeSH Number(s) |
E02.319.267.120.500
|
Concept/Terms |
Administration, Intravaginal- Administration, Intravaginal
- Vaginal Administration
- Administrations, Vaginal
- Vaginal Administrations
- Administration, Vaginal
- Intravaginal Administration
- Administrations, Intravaginal
- Intravaginal Administrations
Instillation, Vaginal- Instillation, Vaginal
- Instillations, Vaginal
- Vaginal Instillation
- Vaginal Instillations
- Vaginal Drug Administration
- Drug Administration, Vaginal
- Administration, Vaginal Drug
- Administrations, Vaginal Drug
- Drug Administrations, Vaginal
- Vaginal Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravaginal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravaginal".
This graph shows the total number of publications written about "Administration, Intravaginal" by people in this website by year, and whether "Administration, Intravaginal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intravaginal" by people in Profiles.
-
Optimal misoprostol dosing among patients with a body mass index greater than 30: a randomized controlled trial. Am J Obstet Gynecol. 2024 05; 230(5):565.e1-565.e16.
-
The association of different progesterone preparations with preterm birth prevention. J Matern Fetal Neonatal Med. 2019 Oct; 32(20):3452-3457.
-
Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy. Breast Cancer Res Treat. 2016 06; 157(2):203-210.
-
Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol. 2015 Oct; 213(4):479-87.
-
Short cervical length dilemma. Obstet Gynecol Clin North Am. 2015 Jun; 42(2):241-54.
-
A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge. Sci Transl Med. 2015 Jan 14; 7(270):270ra4.
-
Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system. J Control Release. 2011 Nov 07; 155(3):418-26.
-
Use of misoprostol for management of unsatisfactory colposcopy in the adolescent: a case report and review of the literature. J Pediatr Adolesc Gynecol. 2009 Oct; 22(5):e139-41.
-
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone. Fertil Steril. 2009 Jul; 92(1):163-9.
-
Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis. 2008 Apr; 12(2):111-7.